ek1-esym-Braun-Matthias

Short Talk: Tumor CD155 Drives Resistance to Immunotherapy by Downregulating the Activating Receptor CD226 in CD8+ T Cells

Date

August 17, 2020

This product is not available for individual purchase, but it is available as part of the following products:

Thumbnail for eSymposia | Advances in Cancer Immunotherapy - Regular Rate

eSymposia | Advances in Cancer Immunotherapy - Regular Rate

Thumbnail for eSymposia | Advances in Cancer Immunotherapy - Student Rate

eSymposia | Advances in Cancer Immunotherapy - Student Rate

Speaker

Matthias Braun, MD

QIMR Berghofer, Australia

Tracks

Mechanisms of Response I

Related Products

Thumbnail for Meet-the-Editors Roundtable

Meet-the-Editors Roundtable

[custom image] [custom image] [custom image]

Thumbnail for eSymposia | Advances in Cancer Immunotherapy

eSymposia | Advances in Cancer Immunotherapy

Thumbnail for KS|QA: Georgina Long, PhD

KS|QA: Georgina Long, PhD

KS|QA WITH FIELD LEADER DR…

Thumbnail for Short Talk: Integrating DNA and RNA Sequencing Analysis to Describe Somatic Alterations and Expression in the HLA Gene Loci

Short Talk: Integrating DNA and RNA Sequencing Analysis to Describe Somatic Alterations and Expression in the HLA Gene Loci

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.